Among the biological CLL prognostic markers the IgVH mutation status or its surrogate markers (ZAP-70 and CD38 expression) as well as genomic aberrations may identify the subjects with more aggressive leukemia and poor prognosis [7, 33]. Here, CD38 is linked to B-cell chronic lymphocytic leukemia.